Omnicom Group Inc., together with its subsidiaries, offers advertising, marketing, and corporate communications services. It provides a range of services in the areas of media and advertising, precision marketing, public relations, healthcare, branding and retail commerce, experiential, execution, and support. The company's services include advertising, branding, content marketing, corporate social responsibility consulting, crisis communications, custom publishing, data analytics, database management, digital/direct marketing and post-production, digital transformation consulting, entertainment marketing, experiential marketing, field marketing, sales support, financial/corporate business-to-business advertising, graphic arts/digital imaging, healthcare marketing and communications, and instore design services. Its services also comprise interactive marketing, investor relations, marketing research, media planning and buying, retail media planning and buying, merchandising and point of sale, mobile marketing, multi-cultural marketing, non-profit marketing, organizational communications, package design, product placement, promotional marketing, public affairs, public relations, retail marketing, retail media and e-commerce, search engine marketing, shopper marketing, social media marketing, and sports and event marketing services. It operates in the North and Latin America, Europe, the Middle East and Africa (EMEA), and the Asia Pacific. The company was incorporated in 1944 and is based in New York, New York.

Omnicom Group Inc.

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Omnicell (OMCL) and Xeris Pharmaceuticals (XERS) wit...

Analysts Are Bullish on Top Healthcare Stocks: Omnicell (OMCL), Xeris Pharmaceuticals (XERS)

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Omnicell (OMCL), Oric Pharmaceuticals (ORIC) and Pfizer (PFE). Om...

Analysts Offer Insights on Healthcare Companies: Omnicell (OMCL), Oric Pharmaceuticals (ORIC) and Pfizer (PFE)

Omnicom Group received a Buy rating and price target from Goldman Sachs analyst Adam Berlin today. According to TipRanks, Berlin is ranked #1572 ou...

Omnicom Group (OMC) Has a New Rating from Goldman Sachs

Rothschild & Co Redburn analyst Bianca Dallal initiated coverage with a Hold rating on Omnicom Group today and set a price target of $89.00. Accord...

Omnicom Group (OMC) Initiated with a Hold at Rothschild & Co Redburn

An announcement from Omnicell ( ($OMCL) ) is now available. On May 19, 2026, Omnicell stockholders held their Annual Meeting and approved all five ...

Current Quarter	$2.64	Next Quarter	$2.88
Current Year	$10.97	Next Year	$12.53
QoQ Growth	+9.1%	YoY Growth	+14.2%
3Y EPS CAGR	-100.0%	Target Price	$102.90
Consensus	Buy	Upside	+44.2%

Current Quarter Rev	N/A	Next Quarter Rev	N/A
Revenue Growth	N/A	YoY Growth	N/A

	A	B	C	D
1	Symbol	Price	Change	Volume
2	OMC	$71.35	-6.50%	24.46M
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	OMC	$71.35	-6.5%	24.46M
3
4
5
6

OMC

OMC

EPS Estimates Overview

EPS Historical Trend (5 Years)

Quarterly EPS Estimates

Revenue Analysis

Get Omnicom Group Inc. Data in Excel

Get Omnicom Group Inc. Data in Excel